BDBM50209121 (2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethoxy]phenyl}-cyclopropyl)acetic acid::CHEMBL226045

SMILES OC(=O)CC1CC1c1ccc(OCCc2ccc3CCCNc3n2)cc1

InChI Key InChIKey=DPFLAGDMGNKRSD-UHFFFAOYSA-N

Data  14 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 14 hits for monomerid = 50209121   

TargetIntegrin alpha-V/beta-3(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 0.600nMAssay Description:Inhibition of human integrin alpha-v-beta-3 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 0.600nMAssay Description:Inhibition of human integrin alpha-v-beta-3 receptor by solid phase receptor assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 4.40nMAssay Description:Inhibition of integrin alpha-v-beta-5 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 4.40nMAssay Description:Inhibition of integrin alpha-v-beta-5 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-1(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 6nMAssay Description:Inhibition of integrin alphavbeta1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 16nMAssay Description:Inhibition of human integrin alpha-v-beta-3 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 16nMAssay Description:Inhibition of human integrin alpha-v-beta-3 receptor by solid phase receptor assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 16nMAssay Description:Inhibition of human integrin alpha-v-beta-3 receptor by solid phase receptor assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 16nMAssay Description:Inhibition of human integrin alpha-v-beta-3 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 33nMAssay Description:Inhibition of integrin alpha-v-beta-5 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-1(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 297nMAssay Description:Inhibition of integrin alphavbeta1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-1(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 297nMAssay Description:Inhibition of integrin alphavbeta1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-6(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of integrin alpha-beta-6 receptor expressed in HT29 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-6(Human)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50209121((2-{4-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of integrin alpha-beta-6 receptor expressed in HT29 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed